TP53 and cancer: Although there is no significant difference in the survival time relative to the studied miRNAs’ expression, some apparent trends can be recognized, but it may require larger group studies and evaluation of other parameters, such as cancer stage or grade, p53 variant, etc., to obtain conclusive results.